| CTXR YTD Return Table | ||||||||||||||||||||||||||||||
CTXR YTD return is presented with the assumption of reinvestments of any dividends on ex-date. |
| YTD Return Benchmarks |
|
Compare CTXR YTD return (see YTD Return Formula;
YTD Return vs Yield) versus benchmarks: YTD Return on S&P YTD Return on Dow YTD Return on Nasdaq 100 YTD Return on Russell 2000 YTD Return on Gold YTD Return on 10 Year Treasury |
| CTXR Share Performance |
| CTXR YTD Return Chart | |||
Also see: CTXR Average Annual Return | |||
| About Citius Pharmaceuticals Inc |
| Citius Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. It develops and commercializes critical care products with a focus on oncology, anti-infectives in adjunct cancer care, prescription products and stem cell therapy. Its products include LYMPHIR, Mino-Lok, Halo-Lido, NoveCite and Mino-Wrap. LYMPHIR is an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter. The CTXR YTD return is shown above.
The YTD Return on the CTXR YTD return page and across the coverage universe of our site, is a measure of the total return for a given investment year-to-date for the current calendar year (up to the end of prior trading session). Arguably, choosing the current calendar year for a measurement period is on the one hand completely arbitrary, but on the other hand a year-to-date look can be extremely useful in the context of our country's tax system which taxes gains and income on a calendar year basis. Thus, researching Year-To-Date Returns is good practice for investors — whether CTXR YTD return or other benchmarks/peers — and when doing so it is also important to factor in dividends, because a financial instrument's YTD return is more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors by performing the CTXR YTD return calculation (with any dividends reinvested as applicable), and to provide a coverage universe of many stocks and ETFs to be able to compare YTD returns. |
| CTXR Current Stock Quote |
 Free CTXR Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Don't Forget Dividends in YTD Return! | |
|
| YTD Return Peers |
| Citius Pharmaceuticals (CTXR) is categorized under the Healthcare sector; to help you further research YTD return performance across stocks, below are some other companies in the same sector:
CUE YTD Return |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 7.6%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 7.6%.
Video: Don't Forget Dividends in YTD Return!